ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 357885 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 357885; 2) Community: the network communities that were significantly associated with the response to NSC 357885; 3) Molecule: the relationships between components within communities and NSC 357885; 4) MDR: the compounds that were significantly associated with the NSC 357885.

NSC Compound Enrichment Correlation
NSC 758965 CEPHARANTHINE 0.0171490505199911 0.028547074
NSC 301477 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-4-O-methyl-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- 0.0171490505199913 0.71923722
NSC 4114 Morpholinium-N-oxydiethylenedithiocarbamate 0.0171490505199913 -0.027955965
NSC 610457 Camptothecin Derivative 0.0171490505199913 0.61755562
NSC 635414 Null 0.0171490505199913 0.15747322
NSC 648114 ANTINEOPLASTIC-D648114 0.0171490505199913 0.74818251
NSC 650931 2'-BROMO-4'-EPI-DAUNDRUBICIN 0.0171490505199913 0.68673677
NSC 67239 as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-, triacetate 0.0171490505199913 0.38280841
NSC 679509 Null 0.0171490505199913 0.29010136
NSC 689297 1H-Pyrido[4,3,2-mn]thiazolo[4,5-b]acridin-9-one 0.0171490505199913 -0.0065279439
Total:45  Current:15    [First] [Prev] [Next] [Last]